Zepp Health (NYSE:ZEPP - Get Free Report)'s stock had its "sell (d-)" rating reiterated by Weiss Ratings in a research note issued on Wednesday,Weiss Ratings reports.
ZEPP has been the subject of a number of other research reports. Fundamental Research set a $60.23 price target on Zepp Health and gave the company a "buy" rating in a research note on Tuesday, August 26th. Wall Street Zen raised shares of Zepp Health to a "hold" rating in a report on Saturday, August 16th. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $60.23.
Check Out Our Latest Report on ZEPP
Zepp Health Trading Down 0.7%
Zepp Health stock traded down $0.41 during trading hours on Wednesday, reaching $56.98. 72,577 shares of the company's stock were exchanged, compared to its average volume of 288,129. The company has a quick ratio of 0.78, a current ratio of 1.10 and a debt-to-equity ratio of 0.31. The firm's 50 day simple moving average is $40.94 and its 200 day simple moving average is $16.86. The firm has a market capitalization of $826.21 million, a PE ratio of -11.80 and a beta of 1.32. Zepp Health has a twelve month low of $2.13 and a twelve month high of $59.90.
Zepp Health Company Profile
(
Get Free Report)
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Zepp Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zepp Health wasn't on the list.
While Zepp Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.